Background: Cardiovascular involvement is common in HIV reactive patients, although are clinically quiescent. Echocardiography in HIV reactive patients is important tool in recognizing these cardiac abnormalities. Methods: The study was conducted in 150 HIV reactive patients attending antiretroviral therapy centre and wards of the hospital. Echocardiography was done using GE Vivid 3 Milwaukee using 2.5 MHz variable frequency transducer and CD4+ count was measured by FACS (Flourescent Activator Cell Sorter). Patients with age <15 years, congenital heart disease, preexisting valvular heart disease, hypertension and diabetes mellitus were excluded from study. Patients were divided into three groups according to CD4+ counts: group 1 with CD4+ count <200, group 2 with 201-350 and group 3 with > 350 CD4+ cells. Data so collected was statistically analysed and correlation with CD4+ count was studied. Results: Out of 150 patients, echocardiographic involvement was shown in 62 (41.3 %) patients. Most common echocardiographic abnormality was diastolic dysfunction in 26 % (most of the patients had grade 1 diastolic dysfunction), followed by pericardial effusion in 8.6 %. 6.7% had systolic dysfunction and 5.3% had features of dilated cardiomyopathy. The mean CD4+ count in patients with grade 1 diastolic dysfunction and systolic dysfunction was significantly lower than in patients without diastolic dysfunction and systolic dysfunction (166.9 versus 210.65). Same was true with patients having pericardial effusion and dilated cardiomyopathy. Pulmonary hypertension was seen in 5.8 % of patients. Conclusion: The prevalence of echocardiographic manifestations in HIV reactive patients was quiet high. High index of clinical suspicion of cardiac involvement and its recognition in HIV patients at all stages help in early diagnosis and treatment which in turn will decrease morbidity and mortality.